Raymundo
Ocaranza Sánchez
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (7)
2023
-
Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)
Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031
2022
-
Adjusting RFR by Predictors of Disagreement, “The Adjusted RFR”: An Alternative Methodology to Improve the Diagnostic Capacity of Coronary Indices
Arquivos Brasileiros de Cardiologia, Vol. 119, Núm. 5, pp. 705-713
-
Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: The SUGAR trial
European Heart Journal, Vol. 43, Núm. 13, pp. 1320-1330
2021
-
Comparison of One-Year Outcomes Between the ihtDEStiny BD Stent and the Durable-Polymer Everolimus- and Zotarolimus-Eluting Stents: A Propensity-Score-Matched Analysis
Cardiovascular Revascularization Medicine, Vol. 31, pp. 1-6
-
Real-world registry of the durable Angiolite fluoroacrylate polymer-based sirolimus-eluting stent: The EPIC02 – RANGO study
REC: Interventional Cardiology, Vol. 3, Núm. 4, pp. 258-266
-
Usefulness of the Hybrid RFR-FFR Approach: Results of a prospective and multicenter analysis of diagnostic agreement between RFR and FFR-The RECOPA (REsting Full-Cycle ratio comparation versus fractional flow reserve (A Prospective Validation)) study
Journal of Interventional Cardiology, Vol. 2021
2020
-
Efectos de la pandemia de COVID-19 sobre la población mayor de 75 años con revascularización coronaria previa: Subanálisis del registro EPIC SIERRA 75
REC: Interventional Cardiology, Vol. 2, Núm. 4, pp. 321-322